Practice moving page:

Article Title: IVF Page Editing

First article edit:

In some cases, laboratory mix-ups (misidentified gametes, transfer of wrong embryos) have occurred, leading to legal action against the IVF provider and complex paternity suits. An example is the case of a woman in California who received the embryo of another couple and was notified of this mistake after the birth of her son. This has led to many authorities and individual clinics implementing procedures to minimize the risk of such mix-ups. Added: To mitigate risks and errors that could impact patients in IVF laboratories, regulatory authorities, along with institutions that assess hazards and ensure the appropriate handling of vulnerable materials such as oocytes and generic materials, were employed in the United Kingdom. This conversation sparked amid governmental concerns regarding the ethical implications of treating infertility in a laboratory setting, where doctors had all of the medical responsibility, along with philosophers such as Mary Warnock voicing their opinions on bridging medicine and politics to optimize safety. In the late 1970s, medical debates challenged the morality of IVF through religious, medical, and scientific claims, which led to the establishment of the Warnock Committee, chaired by Mary Warnock. The committee outsourced ethical decisions to groups outside of doctors, which ultimately led to the issuing of the Warnock Report, which served to regulate IVF and embryo research. In 1990, the UK passed the Human Fertilization and Embryology Act, institutionalizing bioethics as a result. Because of these debates, ethics is handled by experts.^[1]

Second article edit:

In December 2015, the Ontario provincial government enacted the Ontario Fertility Program for patients with medical and non-medical infertility, regardless of sexual orientation, gender or family composition. Eligible patients for IVF treatment must be Ontario residents under the age of 43 and have a valid Ontario Health Insurance Plan card and have not already undergone any IVF cycles. Coverage is extensive, but not universal. Added: Policymakers in Canada have historically debated over whether IVF fits the criteria for funding and ultimately decided to delist it, raising concerns and controversy over whether reproductive health is considered a medical issue worth helping patients with. Because this government delisting forced patients with infertility to pay thousands of dollars out of pocket, activists lobbied for additional funding using the policymakers’ framework. This pressure led to the formation of the Expert Panel, which recommended limited funding based on the idea that IVF was a medical necessity rather than a means of accessing services. Once the Ontario government implemented the Ontario Fertility Program, which funded only one cycle despite advocacy groups insisting that funding multiple cycles can improve outcomes. Because the panel defined “medical necessity” relatively narrowly, arguments for extended funding have often been neutralized. These debates have future implications for how health care spending is given out based on how parameters such as efficiency, medicalization, and immediacy are defined.^[2]